| Literature DB >> 21899754 |
Amy E Green1, Gregory A Aarons.
Abstract
BACKGROUND: The goal of this study was to assess potential differences between administrators/policymakers and those involved in direct practice regarding factors believed to be barriers or facilitating factors to evidence-based practice (EBP) implementation in a large public mental health service system in the United States.Entities:
Mesh:
Year: 2011 PMID: 21899754 PMCID: PMC3178500 DOI: 10.1186/1748-5908-6-104
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Figure 1Policy stakeholder importance cluster rating map.
Figure 2Practice stakeholder importance cluster rating map.
Mean differences in importance ratings for policy and practice groups
| Policy | Practice | T-test; p-value | ES | |||||
|---|---|---|---|---|---|---|---|---|
| Staffing resources | 1 | 3.21 | 0.33 | 5 | 3.11 | 0.44 | 0.27 | |
| Costs of EBP | 2 | 3.13 | 0.53 | 4 | 3.14 | 0.72 | 0.01 | |
| Funding | 3 | 3.11 | 0.35 | 2 | 3.24 | 0.81 | 0.21 | |
| Research and Outcomes Supporting EBP | 4 | 3.09 | 0.44 | 6 | 3.09 | 0.60 | 0.00 | |
| Staff Development and Support | 5 | 3.06 | 0.28 | 1 | 3.28 | 0.49 | 0.55 | |
| Political Dynamics | 6 | 2.92 | 0.60 | 12 | 2.88 | 0.78 | 0.06 | |
| Beneficial features (of EBP) | 7 | 2.82 | 0.47 | 8 | 3.07 | 0.75 | 0.39 | |
| Consumer Values and Marketing | 8 | 2.72 | 0.47 | 9 | 3.05 | 0.69 | 0.54 | |
| Consumer Concerns | 9 | 2.71 | 0.37 | 10 | 3.01 | 0.66 | 0.55 | |
| Clinical Perceptions | 10 | 2.70 | 0.63 | 6 | 3.09 | 0.45 | 0.69 | |
| EBP Limitations | 11 | 2.67 | 0.65 | 14 | 2.74 | 0.69 | 0.10 | |
| System Readiness and Compatibility | 11 | 2.67 | 0.57 | 11 | 2.96 | 0.71 | 0.43 | |
| Agency Compatibility | 13 | 2.52 | 0.47 | 13 | 2.87 | 0.58 | 0.67 | |
| Impact on Clinical Practice | 14 | 2.48 | 0.50 | 3 | 3.21 | 0.59 | 1.33 | |
Mean differences in changeability ratings for policy and practice groups
| Policy | Practice | T-test; p-value | ES | |||||
|---|---|---|---|---|---|---|---|---|
| Clinical Perceptions | 1 | 2.69 | 0.63 | 1 | 2.71 | 0.57 | 0.04 | |
| Staff Development and Support | 2 | 2.57 | 0.35 | 4 | 2.51 | 0.62 | 0.11 | |
| Consumer Values and Marketing | 3 | 2.55 | 0.55 | 3 | 2.57 | 0.62 | 0.04 | |
| Impact on Clinical Practice | 4 | 2.43 | 0.60 | 2 | 2.69 | 0.75 | 0.37 | |
| Consumer Concerns | 5 | 2.42 | 0.56 | 6 | 2.49 | 0.73 | 0.11 | |
| Research and Outcomes supporting EBP | 6 | 2.30 | 0.44 | 4 | 2.51 | 0.55 | 0.42 | |
| Agency Compatibility | 7 | 2.24 | 0.54 | 8 | 2.41 | 0.62 | 0.29 | |
| Beneficial Features (of EBP) | 7 | 2.24 | 0.44 | 14 | 2.24 | 0.80 | 0.00 | |
| Staffing Resources | 9 | 2.17 | 0.49 | 10 | 2.39 | 0.61 | 0.39 | |
| System Readiness and Compatibility | 10 | 2.15 | 0.48 | 6 | 2.49 | 0.60 | 0.61 | |
| Political Dynamics | 11 | 2.10 | 0.74 | 12 | 2.36 | 0.90 | 0.31 | |
| EBP Limitations | 12 | 2.04 | 0.68 | 11 | 2.38 | 0.74 | 0.47 | |
| Costs of EBP | 13 | 1.97 | 0.47 | 9 | 2.40 | 0.70 | 0.71 | |
| Funding | 14 | 1.69 | 0.47 | 13 | 2.26 | 0.97 | 0.75 | |